[Drug therapy of adrenal gland hyperfunction].
D000305:Adrenal Cortex Hormones / Q000037:antagonists & inhibitors*; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D000616:Aminoglutethimide / Q000494:pharmacology / Q000627:therapeutic use; D000963:Antimetabolites / Q000494:pharmacology*; D003937:Diagnosis, Differential; D003632:Dichlorodiphenyldichloroethane / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D008797:Metyrapone / Q000494:pharmacology / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000963:Antimetabolites; D005938:Glucocorticoids; D000616:Aminoglutethimide; D003632:Dichlorodiphenyldichloroethane; D006854:Hydrocortisone; D008797:Metyrapone
Die medikamentöse Therapie der Nebennierenrindenüberfunktion.